| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Deepak Vashishth | |
| P2860 | cites work | Interactions between microstructural and geometrical adaptation in human cortical bone. | Q51200287 |
| The effects of ageing and changes in mineral content in degrading the toughness of human femora | Q59295442 | ||
| Cortical bone tissue resists fatigue fracture by deceleration and arrest of microcrack growth | Q60859890 | ||
| Contribution, development and morphology of microcracking in cortical bone during crack propagation | Q63814532 | ||
| Crack growth resistance in cortical bone: Concept of microcrack toughening | Q63814533 | ||
| Some viscoplastic characteristics of bovine and human cortical bone | Q67931499 | ||
| Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals | Q69051942 | ||
| Isolation, purification and partial characterization of novel fluorophores from aging human insoluble collagen-rich tissue | Q69748354 | ||
| Age-related changes in collagen: the identification of reducible lysine-carbohydrate condensation products | Q70413817 | ||
| Type-I collagen mutation compromises the post-yield behavior of Mov13 long bone | Q71175947 | ||
| The diagnosis of osteoporosis | Q72846752 | ||
| Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles | Q73106325 | ||
| Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose | Q73283922 | ||
| Decline in osteocyte lacunar density in human cortical bone is associated with accumulation of microcracks with age | Q73553574 | ||
| Single-column high-performance liquid chromatographic-fluorescence detection of immature, mature, and senescent cross-links of collagen | Q73842432 | ||
| Changes in the fracture toughness of bone may not be reflected in its mineral density, porosity, and tensile properties | Q74773807 | ||
| Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength | Q78109893 | ||
| Age-dependent microdamage removal following mechanically induced microdamage in trabecular bone in vivo | Q79284482 | ||
| Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae | Q79863234 | ||
| Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats | Q83979831 | ||
| Hierarchy of Bone Microdamage at Multiple Length Scales | Q30494296 | ||
| Bone indentation recovery time correlates with bond reforming time | Q31032492 | ||
| Influence of nonenzymatic glycation on biomechanical properties of cortical bone | Q31967796 | ||
| Bone fragility and collagen cross-links. | Q34586748 | ||
| Effects of non-enzymatic glycation on cancellous bone fragility. | Q35429093 | ||
| Age and bone mass as predictors of fracture in a prospective study | Q35589682 | ||
| Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links | Q35809570 | ||
| The role of collagen in bone strength | Q36338176 | ||
| Age-dependent biomechanical modifications in bone | Q36393386 | ||
| An estimate of the worldwide prevalence and disability associated with osteoporotic fractures | Q36597363 | ||
| Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. | Q38700889 | ||
| The compositional and physicochemical homogeneity of male femoral cortex increases after the sixth decade. | Q40304835 | ||
| Advanced glycation endproduct-specific receptors in rat and mouse osteoblast-like cells: regulation with stages of differentiation | Q40937294 | ||
| Mechanical behavior of damaged trabecular bone | Q41014725 | ||
| Etiology and prevention of age-related hip fractures | Q41039808 | ||
| Bone microdamage and skeletal fragility in osteoporotic and stress fractures | Q41548269 | ||
| Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance | Q41726474 | ||
| A role for advanced glycation end products in diminished bone healing in type 1 diabetes | Q42801450 | ||
| Biochemical changes in the collagenous matrix of osteoporotic avian bone | Q42822115 | ||
| Age-related changes in the human femoral cortex | Q43880901 | ||
| Age-related changes in the collagen network and toughness of bone | Q44058103 | ||
| Relative roles of microdamage and microfracture in the mechanical behavior of trabecular bone | Q44218153 | ||
| Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group | Q44331500 | ||
| The influence of bone morphology on fracture toughness of the human femur and tibia | Q45107549 | ||
| Mechanisms of maturation and ageing of collagen | Q45345441 | ||
| Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis. | Q50517813 | ||
| Rising crack-growth-resistance behavior in cortical bone: implications for toughness measurements. | Q50798635 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 62-66 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | Current osteoporosis reports | Q26841869 |
| P1476 | title | The role of the collagen matrix in skeletal fragility | |
| P478 | volume | 5 |
| Q36296930 | A direct role of collagen glycation in bone fracture |
| Q28551744 | Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice |
| Q33811677 | Are we taking full advantage of the growing number of pharmacological treatment options for osteoporosis? |
| Q26750574 | Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions |
| Q35780843 | Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes |
| Q36633388 | Atypical subtrochanteric femoral shaft fractures: role for mechanics and bone quality |
| Q38747695 | Basis of bone metabolism around dental implants during osseointegration and peri-implant bone loss |
| Q33909788 | Biochemical characterization of major bone-matrix proteins using nanoscale-size bone samples and proteomics methodology. |
| Q58695615 | Biomimetic matrices for rapidly forming mineralized bone tissue based on stem cell-mediated osteogenesis |
| Q47382342 | Bone Mechanical Function and the Gut Microbiota |
| Q41294180 | Bone cells and bone turnover in diabetes mellitus |
| Q26863596 | Bone composition: relationship to bone fragility and antiosteoporotic drug effects |
| Q36597970 | Bone fragility beyond strength and mineral density: Raman spectroscopy predicts femoral fracture toughness in a murine model of rheumatoid arthritis |
| Q35825346 | Bone fragility in type 2 diabetes mellitus |
| Q37056305 | Bone metabolism and fracture risk in type 2 diabetes mellitus |
| Q88950565 | Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes |
| Q36927957 | Bone quality in diabetes |
| Q37323596 | Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. |
| Q51536719 | Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized m |
| Q26853091 | Childhood obesity, bone development, and cardiometabolic risk factors |
| Q37598559 | Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus |
| Q46277861 | Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs |
| Q27300823 | Comprehensive analyses of how tubule occlusion and advanced glycation end-products diminish strength of aged dentin |
| Q35448677 | Defects in cortical microarchitecture among African-American women with type 2 diabetes |
| Q38974687 | Diabetes and Bone Marrow Adiposity |
| Q93364919 | Diabetes pharmacotherapy and effects on the musculoskeletal system |
| Q38195566 | Diabetes, collagen, and bone quality |
| Q90678486 | Diagnosis and management of bone fragility in diabetes: an emerging challenge |
| Q35997620 | Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone |
| Q35925095 | Do Non-collagenous Proteins Affect Skeletal Mechanical Properties? |
| Q91644289 | Effect of diabetes on BMD and TBS values as determinants of bone health in the elderly: Bushehr Elderly Health program |
| Q36032326 | Effects of bone matrix proteins on fracture and fragility in osteoporosis |
| Q53579042 | Effects of fatigue induced damage on the longitudinal fracture resistance of cortical bone. |
| Q51398203 | Effects of losartan treatment on the physicochemical properties of diabetic rat bone. |
| Q51498346 | Effects of resistance training on matrix metalloproteinase-2 activity and biomechanical and physical properties of bone in ovariectomized and intact rats. |
| Q26861856 | Establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bones |
| Q57455729 | Feasibility of Serum Pentosidine Level as a Potential Risk Factor for Osteoporotic Vertebral Compression Fracture |
| Q36248483 | Femoral Neck External Size but not aBMD Predicts Structural and Mass Changes for Women Transitioning Through Menopause |
| Q51733602 | From Tension to Compression: Asymmetric Mechanical Behaviour of Trabecular Bone's Organic Phase. |
| Q92131527 | Genome-wide localization of the polyphenol quercetin in human monocytes |
| Q35101624 | Glycation of human cortical and cancellous bone captures differences in the formation of Maillard reaction products between glucose and ribose |
| Q87406239 | High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control |
| Q35771774 | How tough is brittle bone? Investigating osteogenesis imperfecta in mouse bone |
| Q33716858 | Impaired glucose tolerance attenuates bone accrual by promoting the maturation of osteoblasts: Role of Beclin1-mediated autophagy |
| Q46909890 | Implications of combined ovariectomy and glucocorticoid (dexamethasone) treatment on mineral, microarchitectural, biomechanical and matrix properties of rat bone |
| Q49925304 | Influence of hyperbaric oxygen on biomechanics and structural bone matrix in type 1 diabetes mellitus rats |
| Q38903891 | Insulin Resistance and the IGF-I-Cortical Bone Relationship in Children Ages 9 to 13 Years |
| Q84563754 | Lower osteocalcin and osteopontin contents of the femoral head in hip fracture patients than osteoarthritis patients |
| Q35078802 | Methods for Assessing Bone Quality: A Review |
| Q36355576 | Multiscale Predictors of Femoral Neck In Situ Strength in Aging Women: Contributions of BMD, Cortical Porosity, Reference Point Indentation, and Nonenzymatic Glycation |
| Q43591897 | Multiscale approach including microfibril scale to assess elastic constants of cortical bone based on neural network computation and homogenization method |
| Q44064055 | Nanomechanical properties of mineralised collagen microfibrils based on finite elements method: biomechanical role of cross-links |
| Q98733469 | Nanoscale mechanisms in age-related hip-fractures |
| Q36924625 | Nonenzymatic Glycation and Degree of Mineralization Are Higher in Bone From Fractured Patients With Type 1 Diabetes Mellitus. |
| Q44414030 | Nonenzymatic cross-linking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients |
| Q51602683 | Novel Raman Spectroscopic Biomarkers Indicate That Postyield Damage Denatures Bone's Collagen. |
| Q33872326 | Osteopontin deficiency increases bone fragility but preserves bone mass |
| Q45988732 | Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia. |
| Q26852543 | Regulation of postnatal bone homeostasis by TGFβ |
| Q30249436 | Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes. |
| Q50021725 | Skeletal fragility in diabetes |
| Q37404948 | The contribution of collagen crosslinks to bone strength |
| Q38956808 | The effect of hyperglycaemia on osseointegration: a review of animal models of diabetes mellitus and titanium implant placement |
| Q37101353 | The effect of the microscopic and nanoscale structure on bone fragility |
| Q33667379 | Theoretical consideration of the effect of drug holidays on BMD and tissue age. |
| Q38048186 | Type 2 diabetes and bone |
| Q39874552 | Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment |
| Q37281074 | Variation in type I collagen fibril nanomorphology: the significance and origin |
Search more.